Abstract
Inflammation and innate immune system play a central role in cancers, including those affecting the central nervous system (CNS). Currently, classification of neoplasms, especially regarding gliomas, is established on molecular mutations in isocitrate dehydrogenase (IDH) genes and the presence of co-deletion 1p/19q. Treatment, in most of brain and spinal cord tumors, is centered on surgery, radiotherapy and pharmacological approaches with chemotherapeutic agents. However, the results of the treatments, after several decades, are not completely satisfactory. Cytokines and angiogenic factors are closely linked to the brain cancer behavior. Moreover, recent studies suggest a link between inflammation and tumorigenesis, underlying the complex nature of this topic, especially the anti- and pro-tumoral activities of inflammation and the two-way interactions between immune and tumor cells. The current understanding of the mechanisms by which CNS cancer cells modulate the immune system, especially how bi-directional communications between immune cells and tumor cells create an immunosuppressed microenvironment, gives important information about the promotion of tumor survival and growth. Here, we have briefly reviewed the current literature on this topic, focusing on the possible role of inflammation and innate immunity involved in the origin and in the development of CNS tumors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abd-El-Barr MM, Huang KT, Chi JH (2016) Infiltrating spinal cord astrocytomas: epidemiology, diagnosis, treatments and future directions. J Clin Neurosci: Off J Neurosurg Soc Australas 29:15–20. https://doi.org/10.1016/j.jocn.2015.10.048
Albulescu R et al. (2013) Cytokine patterns in brain tumour progression. Mediators of inflammation 2013
AlRayahi J et al. (2018) Pediatric brain tumor genetics: what radiologists need to know. Radiographics: a review publication of the Radiological Society of North America, Inc 38:2102–2122. https://doi.org/10.1148/rg.2018180109
Bell JS et al. (2019) Global incidence of brain and spinal tumors by geographic region and income level based on cancer registry data. J Clin Neurosci 66:121–127
Bifulco M, Laezza C, Pisanti S, Gazzerro P (2006) Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 148:123–135. https://doi.org/10.1038/sj.bjp.0706632
Bondy ML et al (2008) Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113:1953–1968. https://doi.org/10.1002/cncr.23741
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68:394–424
Brennan CW et al. (2013) The somatic genomic landscape of glioblastoma. Cell 155:462–477. https://doi.org/10.1016/j.cell.2013.09.034
Bush NA, Chang SM, Berger MS (2017) Current and future strategies for treatment of glioma. Neurosurg Rev 40:1–14. https://doi.org/10.1007/s10143-016-0709-8
Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H (2012) The brain tumor microenvironment. Glia 60:502–514. https://doi.org/10.1002/glia.21264
Chen H, Li M, Guo Y, Zhong Y, He Z, Xu Y, Zou J (2020) Immune response in glioma’s microenvironment. Innov Surg Sci 5:20190001. https://doi.org/10.1515/iss-2019-0001
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867. https://doi.org/10.1038/nature01322
Deng S, Zhu S, Qiao Y, Liu YJ, Chen W, Zhao G, Chen J (2014) Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma. Protein & Cell 5:899–911. https://doi.org/10.1007/s13238-014-0112-6
Di Marzo V (2009) The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 60:77–84. https://doi.org/10.1016/j.phrs.2009.02.010
Domingues PH et al (2012) Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas. Am J Pathol 181:1749–1761. https://doi.org/10.1016/j.ajpath.2012.07.033
Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158:1021–1029. https://doi.org/10.1016/j.neuroscience.2008.06.052
Fecci PE et al. (2006) Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clin Cancer Res: Off J Am Assoc Cancer Res 12:4294–4305. https://doi.org/10.1158/1078-0432.ccr-06-0053
Galvão RP, Zong H (2013) Inflammation and gliomagenesis: bi-directional communication at early and late stages of tumor progression. Curr Pathobiol Rep 1:19–28. https://doi.org/10.1007/s40139-012-0006-3
Garzon-Muvdi T, Bailey DD, Pernik MN, Pan E (2020) Basis for immunotherapy for treatment of meningiomas. Front Neurol 11:945. https://doi.org/10.3389/fneur.2020.00945
Giometto B, Bozza F, Faresin F, Alessio L, Mingrino S, Tavolato B (1996) Immune infiltrates and cytokines in gliomas. Acta Neurochir 138:50–56. https://doi.org/10.1007/bf01411724
Hamtiaux L, Masquelier J, Muccioli GG, Bouzin C, Feron O, Gallez B, Lambert DM (2012) The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. BMC Cancer 12:92. https://doi.org/10.1186/1471-2407-12-92
Hua CZ et al. (2018) Streptococcal toxic shock syndrome caused by Streptococcus pyogenes: a retrospective study of 15 pediatric cases. Zhonghua Er Ke Za Zhi 56:587–591. https://doi.org/10.3760/cma.j.issn.0578-1310.2018.08.006
Huettner C, Paulus W, Roggendorf W (1994) Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme. Verhandlungen der Deutschen Gesellschaft fur Pathologie 78:418–422
Husain SR, Kawakami K, Kawakami M, Puri RK (2003) Interleukin-4 receptor-targeted cytotoxin therapy of androgen-dependent and -independent prostate carcinoma in xenograft models. Mol Cancer Ther 2:245–254
Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB (2006) The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol 8:261–279. https://doi.org/10.1215/15228517-2006-008
Jiang H, Cui Y, Wang J, Lin S (2017) Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system. Oncotarget 8:20354–20361. https://doi.org/10.18632/oncotarget.13555
Kamran N et al (2017) Immunosuppressive myeloid cells’ blockade in the glioma microenvironment enhances the efficacy of immune-stimulatory gene therapy. Mol Ther: J Am Soc Gene Ther 25:232–248. https://doi.org/10.1016/j.ymthe.2016.10.003
Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521–535. https://doi.org/10.1007/s00401-017-1769-8
Louis DN, Holland EC, Cairncross JG (2001) Glioma classification: a molecular reappraisal. Am J Pathol 159:779–786. https://doi.org/10.1016/s0002-9440(10)61750-6
Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A (2000) Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 275:31938–31945. https://doi.org/10.1074/jbc.M005722200
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-Related Inflammation. Nature 454:436–444. https://doi.org/10.1038/nature07205
Massi P, Valenti M, Solinas M, Parolaro D (2010) Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress. Cancers 2:1013–1026. https://doi.org/10.3390/cancers2021013
Mesfin FB, Al-Dhahir MA (2022) Gliomas. In: StatPearls. StatPearls Publishing. Copyright © 2022, StatPearls Publishing LLC., Treasure Island (FL)
Nazıroğlu M, Taner AN, Balbay E, Çiğ B (2019) Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model. Mol Cell Biochem 453:143–155. https://doi.org/10.1007/s11010-018-3439-0
Ng HK, Sun DT, Poon WS (2002) Anaplastic oligodendroglioma with drop metastasis to the spinal cord. Clin Neurol Neurosurg 104:383–386. https://doi.org/10.1016/s0303-8467(02)00011-2
O’Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol 7:353–364. https://doi.org/10.1038/nri2079
Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS STATISTICAL REPORT: PRIMARY BRAIN AND OTHER CENTRAL nervous system tumors diagnosed in the United States in 2010–2014. Neuro-oncology 19:v1–v88. https://doi.org/10.1093/neuonc/nox158
Parney IF, Waldron JS, Parsa AT (2009) Flow cytometry and in vitro analysis of human glioma-associated macrophages. Lab Investig J Neurosurg 110:572–582. https://doi.org/10.3171/2008.7.JNS08475
Peng G et al. (2005) Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science (New York, NY) 309:1380–1384. https://doi.org/10.1126/science.1113401
Piomelli D (2005) The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs (Lond Engl: 2000) 6:672–679
Salvati M, Caroli E, Rocchi G, Frati A, Brogna C, Orlando ER (2004) Post-traumatic glioma. Rep Four Cases Rev Lit Tumori 90:416–419
Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar H (2008) Cannabinoids for cancer treatment: progress and promise. Can Res 68:339–342. https://doi.org/10.1158/0008-5472.can-07-2785
Schartner JM, Hagar AR, Van Handel M, Zhang L, Nadkarni N, Badie B (2005) Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51:279–285. https://doi.org/10.1002/glia.20201
Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762–774. https://doi.org/10.1038/nri3070
Sowers JL, Johnson KM, Conrad C, Patterson JT, Sowers LC (2014) The role of inflammation in brain cancer. Inflamm Cancer 75–105
Strik HM, Stoll M, Meyermann R (2004) Immune cell infiltration of intrinsic and metastatic intracranial tumours. Anticancer Res 24:37–42
Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330
Verhaak RG et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell 17:98–110. https://doi.org/10.1016/j.ccr.2009.12.020
Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507. https://doi.org/10.1056/NEJMra0708126
Zhu Z, Zhong S, Shen Z (2011) Targeting the inflammatory pathways to enhance chemotherapy of cancer. Cancer Biol & Ther 12:95–105
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Casili, G., Paterniti, I., Campolo, M., Esposito, E., Cuzzocrea, S. (2023). The Role of Neuro-Inflammation and Innate Immunity in Pathophysiology of Brain and Spinal Cord Tumors. In: Rezaei, N., Hanaei, S. (eds) Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1. Advances in Experimental Medicine and Biology, vol 1394. Springer, Cham. https://doi.org/10.1007/978-3-031-14732-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-14732-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14731-9
Online ISBN: 978-3-031-14732-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)